Preventing nausea and vomiting after gynecologic laparoscopic surgery
This trial tests a medication called amisulpride to see if it can prevent nausea and vomiting after laparoscopic surgery on the female reproductive organs. It is given during surgery to help you feel better afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 30 on the body mass index (BMI) scale
- You are having gynecologic laparoscopic surgery (on the ovaries, fallopian tubes, uterus, or related areas) expected to last 3 hours or less
- You are not currently pregnant or breastfeeding
- You are not allergic to any of the study medications
- You have not taken anti-nausea medication or had preventive anti-nausea treatment in the 7 days before surgery
- You do not have chronic dizziness or inner ear problems, or a history of being easily nauseous
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a medicine used during anesthesia might affect another medicine that helps prevent nausea and vomiting after surgery. It may help improve how patients feel after their operation.
This trial studies whether TEAS (a noninvasive electrical stimulation you receive during surgery) can reduce nausea and vomiting after spinal surgery. You might benefit if you’re at risk of “PONV” (post-surgery nausea and vomiting) and can safely take part in an acupoint-based stimulation study.
This study tests whether delivering lidocaine (a numbing medication) through a feeding tube during weight-loss surgery can reduce nausea and vomiting afterward. You would receive this medication as part of the surgery procedure to see if it helps you feel better in recovery.
This study tests whether combining different methods can reduce nausea and vomiting after gynecologic laparoscopic surgery. It may help you feel better sooner after your operation.
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
Hear when a new PONV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.